A detailed history of Trust CO Of Kansas transactions in Abb Vie Inc. stock. As of the latest transaction made, Trust CO Of Kansas holds 2,097 shares of ABBV stock, worth $348,018. This represents 0.21% of its overall portfolio holdings.

Number of Shares
2,097
Previous 2,197 4.55%
Holding current value
$348,018
Previous $340,000 12.35%
% of portfolio
0.21%
Previous 0.19%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$159.82 - $182.1 $15,982 - $18,210
-100 Reduced 4.55%
2,097 $382,000
Q4 2023

Feb 01, 2024

SELL
$137.6 - $154.97 $5,504 - $6,198
-40 Reduced 1.79%
2,197 $340,000
Q3 2023

Feb 01, 2024

BUY
$133.59 - $154.65 $5,343 - $6,186
40 Added 1.82%
2,237 $333,000
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $26,851 - $31,084
201 Added 9.87%
2,237 $333,000
Q2 2023

Aug 04, 2023

SELL
$132.51 - $164.9 $14,576 - $18,139
-110 Reduced 5.13%
2,036 $274,000
Q1 2023

May 05, 2023

SELL
$144.61 - $166.54 $30,078 - $34,640
-208 Reduced 8.84%
2,146 $342,000
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $46,610 - $55,898
-337 Reduced 12.52%
2,354 $380,000
Q3 2022

Nov 17, 2022

SELL
$134.21 - $153.93 $35,028 - $40,175
-261 Reduced 8.84%
2,691 $361,000
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $2,752 - $3,499
-20 Reduced 0.67%
2,952 $452,000
Q1 2022

May 17, 2022

SELL
$131.98 - $163.75 $4,619 - $5,731
-35 Reduced 1.16%
2,972 $482,000
Q4 2021

Feb 15, 2022

SELL
$107.43 - $135.93 $19,874 - $25,147
-185 Reduced 5.8%
3,007 $407,000
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $4,043 - $4,589
38 Added 1.2%
3,192 $344,000
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $19,674 - $21,918
-187 Reduced 5.6%
3,154 $355,000
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $108,131 - $119,039
1,057 Added 46.28%
3,341 $362,000
Q4 2020

Feb 17, 2021

SELL
$80.49 - $108.67 $4.29 Million - $5.79 Million
-53,321 Reduced 95.89%
2,284 $245,000
Q3 2020

Dec 18, 2020

SELL
$85.91 - $100.83 $724,479 - $850,299
-8,433 Reduced 13.17%
55,605 $4.87 Million
Q2 2020

Aug 17, 2020

BUY
$73.37 - $98.18 $32,209 - $43,101
439 Added 0.69%
64,038 $6.29 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $362,748 - $549,970
5,624 Added 9.7%
63,599 $4.85 Million
Q4 2019

Feb 20, 2020

BUY
$72.13 - $90.25 $4.18 Million - $5.23 Million
57,975 New
57,975 $5.13 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Trust CO Of Kansas Portfolio

Follow Trust CO Of Kansas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Kansas, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Kansas with notifications on news.